Parkman Healthcare Partners’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-110,547
Closed -$371K 101
2020
Q4
$371K Buy
+110,547
New +$371K 0.1% 82
2020
Q1
Sell
-91,091
Closed -$557K 81
2019
Q4
$557K Buy
+91,091
New +$557K 0.16% 65